Cargando…
Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity
Tissue damage elicits cell fate switching through a process called metaplasia, but how the starting cell fate is silenced and the new cell fate is activated has not been investigated in animals. In cell culture, pioneer transcription factors mediate “reprogramming” by opening new chromatin sites for...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948957/ https://www.ncbi.nlm.nih.gov/pubmed/36824858 http://dx.doi.org/10.1101/2023.02.14.528556 |
_version_ | 1784892884605992960 |
---|---|
author | Katsuda, Takeshi Sussman, Jonathan Ito, Kenji Katznelson, Andrew Yuan, Salina Li, Jinyang Merrell, Allyson J. Takenaka, Naomi Cure, Hector Li, Qinglan Rasool, Reyaz Ur Asangani, Irfan A. Zaret, Kenneth S. Stanger, Ben Z. |
author_facet | Katsuda, Takeshi Sussman, Jonathan Ito, Kenji Katznelson, Andrew Yuan, Salina Li, Jinyang Merrell, Allyson J. Takenaka, Naomi Cure, Hector Li, Qinglan Rasool, Reyaz Ur Asangani, Irfan A. Zaret, Kenneth S. Stanger, Ben Z. |
author_sort | Katsuda, Takeshi |
collection | PubMed |
description | Tissue damage elicits cell fate switching through a process called metaplasia, but how the starting cell fate is silenced and the new cell fate is activated has not been investigated in animals. In cell culture, pioneer transcription factors mediate “reprogramming” by opening new chromatin sites for expression that can attract transcription factors from the starting cell’s enhancers. Here we report that Sox4 is sufficient to initiate hepatobiliary metaplasia in the adult liver. In lineage-traced cells, we assessed the timing of Sox4-mediated opening of enhancer chromatin versus enhancer decommissioning. Initially, Sox4 directly binds to and closes hepatocyte regulatory sequences via a motif it overlaps with Hnf4a, a hepatocyte master regulator. Subsequently, Sox4 exerts pioneer factor activity to open biliary regulatory sequences. The results delineate a hierarchy by which gene networks become reprogrammed under physiological conditions, providing deeper insight into the basis for cell fate transitions in animals. |
format | Online Article Text |
id | pubmed-9948957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-99489572023-02-24 Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity Katsuda, Takeshi Sussman, Jonathan Ito, Kenji Katznelson, Andrew Yuan, Salina Li, Jinyang Merrell, Allyson J. Takenaka, Naomi Cure, Hector Li, Qinglan Rasool, Reyaz Ur Asangani, Irfan A. Zaret, Kenneth S. Stanger, Ben Z. bioRxiv Article Tissue damage elicits cell fate switching through a process called metaplasia, but how the starting cell fate is silenced and the new cell fate is activated has not been investigated in animals. In cell culture, pioneer transcription factors mediate “reprogramming” by opening new chromatin sites for expression that can attract transcription factors from the starting cell’s enhancers. Here we report that Sox4 is sufficient to initiate hepatobiliary metaplasia in the adult liver. In lineage-traced cells, we assessed the timing of Sox4-mediated opening of enhancer chromatin versus enhancer decommissioning. Initially, Sox4 directly binds to and closes hepatocyte regulatory sequences via a motif it overlaps with Hnf4a, a hepatocyte master regulator. Subsequently, Sox4 exerts pioneer factor activity to open biliary regulatory sequences. The results delineate a hierarchy by which gene networks become reprogrammed under physiological conditions, providing deeper insight into the basis for cell fate transitions in animals. Cold Spring Harbor Laboratory 2023-02-14 /pmc/articles/PMC9948957/ /pubmed/36824858 http://dx.doi.org/10.1101/2023.02.14.528556 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Katsuda, Takeshi Sussman, Jonathan Ito, Kenji Katznelson, Andrew Yuan, Salina Li, Jinyang Merrell, Allyson J. Takenaka, Naomi Cure, Hector Li, Qinglan Rasool, Reyaz Ur Asangani, Irfan A. Zaret, Kenneth S. Stanger, Ben Z. Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity |
title | Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity |
title_full | Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity |
title_fullStr | Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity |
title_full_unstemmed | Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity |
title_short | Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity |
title_sort | physiological reprogramming in vivo mediated by sox4 pioneer factor activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948957/ https://www.ncbi.nlm.nih.gov/pubmed/36824858 http://dx.doi.org/10.1101/2023.02.14.528556 |
work_keys_str_mv | AT katsudatakeshi physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT sussmanjonathan physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT itokenji physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT katznelsonandrew physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT yuansalina physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT lijinyang physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT merrellallysonj physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT takenakanaomi physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT curehector physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT liqinglan physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT rasoolreyazur physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT asanganiirfana physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT zaretkenneths physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity AT stangerbenz physiologicalreprogramminginvivomediatedbysox4pioneerfactoractivity |